Let’s Not Wait for the Next Crisis to Act on Medicine Supply Security
In today’s rapidly evolving landscape, Europe’s ability to manufacture foundational medicines is under growing pressure. In this blog, Centrient CEO Rex Clements explores why local antibiotic production is at risk — and what must be done to protect public health and ensure a resilient, sustainable supply. Read on to learn what’s at stake and how Centrient is stepping up.
read more